Daily briefing: Pfizer–BioNTech vaccine looks promising for young children

Nature, Published online: 20 September 2021; doi:10.1038/d41586-021-02579-3

A child-size dose of the Pfizer vaccine is safe and generates a robust antibody response in children ages 5 to 11, say the companies. Plus, the mysterious hotness of the Sun’s corona.